| Peer-Reviewed

Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa

Received: 1 May 2018     Accepted: 29 May 2018     Published: 12 June 2018
Views:       Downloads:
Abstract

Objective: To evaluate the effect of artery sequential interventional therapy (internal iliac artery catheterization and occlusion/ uterine artery or internal iliac artery embolization) on the hemorrhage of pernicious placenta previa. Method: The total of 29 patients with pernicious placenta previa and risk factor of placenta accreta from March 2012 to June 2013 in our hospital were included as control group, who were given traditional method of treatment, while 40 patients with the same disease status from July 2013 to October 2014 as treatment group with artery sequential interventional therapy. The amount of blood loss during operation and red blood cell suspension transfusion, the rate of hysterectomy cesarean time, the amount of cesarean section hemorrhage after 24 hours, duration of postopera tive hospital stay, the time of postoperative antibiotic usage and the prevalence of complications (pain, fever, infection and others) of patients in two groups were evaluated, respectively. Result: The significant difference of amount of blood loss during operation [(868.5±549.77) ml vs. (1506.90±1417.39) ml for treatment group and control group, respectively)] and red blood cell suspension transfusion [(1.50±1.40) U vs. (2.72±2.00) U], the rate of hysterectomy (2.50% vs. 17.24%), cesarean time [(58.86±20.33) min vs. (70.83±29.26) min)] and the prevalence of pain (81.25% vs. 48.28%) and other complications (0.00% vs. 10.35%) (all p values < 0.05) were observed, but not for the amount of cesarean section hemorrhage after 24 hours [(271.66±221.55ml) vs. (255.24±249.47 ml)], the duration of postoperative hospital stay [(5.28±1.66) d vs. (5.69±1.58) d], the time of postoperative antibiotic usage [(3.70±2.16) d vs. (3.48±2.06) d], the pain score [(2.64±0.89) vs. (2.67±1.06)], the prevalence of fever (62.50% vs. 55.17%) and inflammation (5.00% vs. 6.90%) (all p values > 0.05). All patients resumed normal menstruation after weaned for 1 to 3 month and the routine newborn physical examination on 42 days after birth, blood analysis, liver function and neurological examination of infants were normal without blood diseases. Conclusion: Artery sequential interventional therapy for patients with pernicious placenta previa was safe, effective and feasible for pregnant and newborn.

Published in Journal of Gynecology and Obstetrics (Volume 6, Issue 3)
DOI 10.11648/j.jgo.20180603.12
Page(s) 40-46
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Artery Sequencial Interventional Treatment, Pernicious Placenta Previa, Internal Iliac Artery Catheterization, Internal Iliac Artery Occlusion, Uterine Artery Embolization, Internal Iliac Artery Embolization

References
[1] Chattopadhyay SK, Kharif H, Sherbeeni MM. Placenta previa and accreta after previous caesarean section [J]. Eur J Obstet Gynecol Reprod Biol, 1993, 52: 151- 156.
[2] Ying H, Ruan CM, Wang DF. The diagnosis and treatment progress of placenta increta [J]. J Pract Obstet and Gynecol, 2007, 23 (6): 335-336.
[3] Zhu NF. Nursing care of 6 pregnant women with implantable dangerous placenta previa treated by femoral artery preset tube embolization [J]. Chinese Journal of Nursing, 2012, 47 (9), 796-798.
[4] Zhou YJ. Pernicious placenta previa 22 cases of clinical analysis [J]. Zhejiang Med J, 2008, 30 (12): 1379.1381.
[5] Li DH, Yang AJ, Li XP, et al. Pregnangy with placenta previa and penetrating the placenta in 2 cases after cesarean delivery [J]. J Pract Obstet and Gynecol, 2007, 23 (9): 544.
[6] JIANG QY, DU XH, ZHANG Q, et al. Application value of lower abdominal aorta compression in hysterectomy for pernicious placenta previa [J]. West China Medical Journal, 2017, 32 (10): 1529-1532.
[7] Fu M, Guo J. Emergency arterial embolization clinical observation for the treatment of intractable postpartum hemorrhage [J]. Progress in Obstetrics and Gynecology, 2007, 16 (6): 469—470.
[8] Luan XF. The application of placenta prtevia cesarean section preoperative uterine arterry catheterization and intraoperative uterine arterry embolization to prevention and treatment of postpartum hemorrhage [J]. Maternal and Child Health Care of China, 2010, 27: 3874-3876.
[9] Dai JR, Tao JY, Hou SY. Late pregnancy femoral artery catheterization and artery embolization to treat pernicious placenta previa combing placenta implantation 4 cases [J]. J Pract Obstet and Gynecol, 2011, 27 (5): 388-390.
[10] Ashworth MD, Ross JW, Stein DR, et a1. Endocrine disruption of uterine insulin-like growth factor expression in the pregnant gilt [J]. Reproduction, 2005.130 (4): 545-551.
[11] Publications Committee, Society for Maternal- Fetal Medicine, Belfort MA. Placenta accreta [J]. Am J Obstet Gynecol, 2010, 203: 430-439.
[12] Lu SS, Zou L. Precautions of postpartum hemorrhage caused by pernicious placenta previa [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2014, 30 (4): 256-259.
[13] Sumigama S, Itakura A, Ota T, et al. Placenta previa increta/percreta in Japan a retrospective study of ultrasound findings management and clinical course [J]. J Obstet Gynaecol Res, 2007, 33 (5): 606-611.
[14] Yan XL, Chen C, Chang Q, et al. Clinical analysis of 20 cases of pernicious placenta previa [J]. Journal of Practical Obstetrics and Gynecology, 2013, 29 (9): 704-707.
[15] Hou QN, Chang Li, Zhou Hui. Maternal Outcomes of Placental Position in Placental Previa Patients with Scar Uterine [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics (Electronic Edition), 2014, 10 (1): 83-86.
[16] Li MY, Zheng WW. The dangers of pernicious placenta previa on maternal. Guangdong Med J, 2001, 22 (5): 428-429.
[17] Jarapuemada JM. Surgical training in selective pelvic arterialligation or use of embolization only [J]. Am J Gynecol, 2000, 182 (2): 252-256.
[18] Hsin-hung W, Guang-Pemg Y. Uterinecavetysynechiae after hemostatic squaresuturing techneque [J]. Obstet Gynecol, 2005, 105 (5): 1176-1178.
[19] Chen CL, Li XM, Li GL, et al. Application of interventional radiology in severe postpartum hemorrhage [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2001, 17 (2): 84.
[20] LU SS, ZOU L. Precautions of postpartum hemorrhage caused by pernicious placenta previa [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2014, 30 (4): 256-259.
[21] Brown BJ, Heaston DK, Poulson Am, et al. Uncontrollable postpartum bleeding: a new approach to hemostasis through angiographic arterial embolization [J]. Obstet Gynecol, 1997, 54 (2): 361-365.
[22] Zhou Q, Zhao YP. Postpartum hemorrhage vascular interventional treatment progress [J]. Journal of Practical Obstetrics and Gynecology, 2005, 22 (4): 197-199.
[23] Vegas G. Selective pelvic arterial embolization in the management of obstetric hemorrhage [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2006, 127: 68-72.
[24] Li LS, He NS, Zhou YH. Interventional radiology-basis and methods [M]. Beijing: People's Medical Publishing House, 2005: 116.
[25] Zhang JN, Zhong SZ. Basin of abdominal vascular anatomy [M]. Guangdong Science and Technology Press, 1997: 145-148.
[26] Du LF, Huang F, Chen W. The causes of placenta previa and prevention and treatment [J]. Maternal and Child Health Care of China, 2010, 25 (11): 1490-1491.
[27] Liu HQ. Progress of interventional treatment of intractable postpartum hemorrhage [J]. Contemporary Medicine, 2010, 16 (5): 117-118.
[28] Eriksson LG, Mulic-Lutvica A, Jangland L, et al. Massive postpartum hemorrhage treated with transcatheter arterial embolization: technicalaspects and long-term effects on fertility and menstrualcycle [J]. Acta Radiol, 2007, 48: 635-642.
[29] American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 266. Placenta accreta [J]. Obstet Gynecol, 2002, 99 (1): 169-170.
[30] Chen CL, Ma B, Fang YC, et al. Transcatheter arterial embolization in intractable postpartum hemorrhage [J]. Chin J Obstet and Gynecol, 2001, 36 (3): 133-136.
[31] Zhou X, Zhang GY, Sun L H, et al.. Analysis of the perioperative integrated operation approaches in pernicious placenta previa [J]. Journal of Practical Obstetrics and Gynecology, 2013, 29 (7): 516-518.
[32] Brent RL. Utiliztaion of developmental basic science principles in the evaluation of reproductive risks from pre-and postconception environmental radiation exposure [J]. Teratology, 1999, 59 (4): 183-204.
[33] Thabet A, Kalva SP, Liu B, et al. Interventional radiology in pregnancy complications: indications, technique, and methods for minimizing radiation exposure [J]. Radiographics, 2012, 32 (1): 255-274.
[34] Zhang GL, Jiang YN, Ma R M, et al. The application of temporary balloon occlusion of the internal iliac artery in performing cesarean hysterectomy for patients with pernicious placenta previa: an initial experience in five cases [J]. Journal of Interventional Radiology, 2012, 21 (12): 991-994.
[35] Geng X, Yang ZG, Si HB, et al. The study of radiation dose in the procedure of uterine arterial embolization adjuvant to the cesarean section for the treatment of puerpera with pernicious placenta previa [J]. Journal of Nantong University (Medical Sciences), 2013: 33 (5) 382-384.
Cite This Article
  • APA Style

    Limin Wang, Dan Luo, Hui Zhou, Chong Xie, Xingtao Liu, et al. (2018). Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa. Journal of Gynecology and Obstetrics, 6(3), 40-46. https://doi.org/10.11648/j.jgo.20180603.12

    Copy | Download

    ACS Style

    Limin Wang; Dan Luo; Hui Zhou; Chong Xie; Xingtao Liu, et al. Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa. J. Gynecol. Obstet. 2018, 6(3), 40-46. doi: 10.11648/j.jgo.20180603.12

    Copy | Download

    AMA Style

    Limin Wang, Dan Luo, Hui Zhou, Chong Xie, Xingtao Liu, et al. Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa. J Gynecol Obstet. 2018;6(3):40-46. doi: 10.11648/j.jgo.20180603.12

    Copy | Download

  • @article{10.11648/j.jgo.20180603.12,
      author = {Limin Wang and Dan Luo and Hui Zhou and Chong Xie and Xingtao Liu and Liqun Li and Hu Zhao and Jiaji Zhang and Qiannan Hou and Wenjie Qing},
      title = {Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa},
      journal = {Journal of Gynecology and Obstetrics},
      volume = {6},
      number = {3},
      pages = {40-46},
      doi = {10.11648/j.jgo.20180603.12},
      url = {https://doi.org/10.11648/j.jgo.20180603.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20180603.12},
      abstract = {Objective: To evaluate the effect of artery sequential interventional therapy (internal iliac artery catheterization and occlusion/ uterine artery or internal iliac artery embolization) on the hemorrhage of pernicious placenta previa. Method: The total of 29 patients with pernicious placenta previa and risk factor of placenta accreta from March 2012 to June 2013 in our hospital were included as control group, who were given traditional method of treatment, while 40 patients with the same disease status from July 2013 to October 2014 as treatment group with artery sequential interventional therapy. The amount of blood loss during operation and red blood cell suspension transfusion, the rate of hysterectomy cesarean time, the amount of cesarean section hemorrhage after 24 hours, duration of postopera tive hospital stay, the time of postoperative antibiotic usage and the prevalence of complications (pain, fever, infection and others) of patients in two groups were evaluated, respectively. Result: The significant difference of amount of blood loss during operation [(868.5±549.77) ml vs. (1506.90±1417.39) ml for treatment group and control group, respectively)] and red blood cell suspension transfusion [(1.50±1.40) U vs. (2.72±2.00) U], the rate of hysterectomy (2.50% vs. 17.24%), cesarean time [(58.86±20.33) min vs. (70.83±29.26) min)] and the prevalence of pain (81.25% vs. 48.28%) and other complications (0.00% vs. 10.35%) (all p values  0.05). All patients resumed normal menstruation after weaned for 1 to 3 month and the routine newborn physical examination on 42 days after birth, blood analysis, liver function and neurological examination of infants were normal without blood diseases. Conclusion: Artery sequential interventional therapy for patients with pernicious placenta previa was safe, effective and feasible for pregnant and newborn.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Evaluation of Artery Sequential Interventional Therapy on Pernicious Placenta Previa
    AU  - Limin Wang
    AU  - Dan Luo
    AU  - Hui Zhou
    AU  - Chong Xie
    AU  - Xingtao Liu
    AU  - Liqun Li
    AU  - Hu Zhao
    AU  - Jiaji Zhang
    AU  - Qiannan Hou
    AU  - Wenjie Qing
    Y1  - 2018/06/12
    PY  - 2018
    N1  - https://doi.org/10.11648/j.jgo.20180603.12
    DO  - 10.11648/j.jgo.20180603.12
    T2  - Journal of Gynecology and Obstetrics
    JF  - Journal of Gynecology and Obstetrics
    JO  - Journal of Gynecology and Obstetrics
    SP  - 40
    EP  - 46
    PB  - Science Publishing Group
    SN  - 2376-7820
    UR  - https://doi.org/10.11648/j.jgo.20180603.12
    AB  - Objective: To evaluate the effect of artery sequential interventional therapy (internal iliac artery catheterization and occlusion/ uterine artery or internal iliac artery embolization) on the hemorrhage of pernicious placenta previa. Method: The total of 29 patients with pernicious placenta previa and risk factor of placenta accreta from March 2012 to June 2013 in our hospital were included as control group, who were given traditional method of treatment, while 40 patients with the same disease status from July 2013 to October 2014 as treatment group with artery sequential interventional therapy. The amount of blood loss during operation and red blood cell suspension transfusion, the rate of hysterectomy cesarean time, the amount of cesarean section hemorrhage after 24 hours, duration of postopera tive hospital stay, the time of postoperative antibiotic usage and the prevalence of complications (pain, fever, infection and others) of patients in two groups were evaluated, respectively. Result: The significant difference of amount of blood loss during operation [(868.5±549.77) ml vs. (1506.90±1417.39) ml for treatment group and control group, respectively)] and red blood cell suspension transfusion [(1.50±1.40) U vs. (2.72±2.00) U], the rate of hysterectomy (2.50% vs. 17.24%), cesarean time [(58.86±20.33) min vs. (70.83±29.26) min)] and the prevalence of pain (81.25% vs. 48.28%) and other complications (0.00% vs. 10.35%) (all p values  0.05). All patients resumed normal menstruation after weaned for 1 to 3 month and the routine newborn physical examination on 42 days after birth, blood analysis, liver function and neurological examination of infants were normal without blood diseases. Conclusion: Artery sequential interventional therapy for patients with pernicious placenta previa was safe, effective and feasible for pregnant and newborn.
    VL  - 6
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Radiology, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Radiology, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Radiology, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Department of Obstetrics, Chengdu Women’s and Children’s Central Hospital, Chengdu, China

  • Sections